Editorial: Metabolic Changes After Kidney Transplantation

Editorial: Metabolic Changes After Kidney Transplantation

Bibliographic Details
Main Authors:	Ekamol Tantisattamo, Bing T. Ho, Biruh T. Workeneh
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-07-01
Series:	Frontiers in Medicine
Subjects:	chronic kidney disease-mineral bone disorders electrolyte disturbances hypertension living donor metabolic changes metabolic syndrome
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.709644/full

Similar Items

Iatrogenic Persistent Hypophosphatemia In A Simultaneous Liver-Kidney Transplant Recipient
by: Ekamol Tantisattamo, et al.
Published: (2012-06-01)

Approach and Management of Hypertension After Kidney Transplantation
by: Ekamol Tantisattamo, et al.
Published: (2020-06-01)

Refractory tertiary hyperparathyroidism after calcimimetics and delayed parathyroidectomy in a kidney transplant recipient
by: Ekamol Tantisattamo, et al.
Published: (2012-06-01)

electrolyte-free water clearance: a clinical utility in managing osmotic urea diuresis-associated polyuria in tube feeding syndrome
by: Ekamol Tantisattamo, et al.
Published: (2012-06-01)

Primary Hyperaldosteronism As A Risk Factor For Recurrent Nephrolithiasis
by: Ekamol Tantisattamo, et al.
Published: (2012-06-01)

Life-Threatening Hypernatremia In A Case Of Diabetes Insipidus/Panhypopituitarism
by: Ekamol Tantisattamo, et al.
Published: (2012-06-01)

PO-04 REBOUND WEIGHT GAIN AND BLOOD PRESSURE CONTROL AFTER LIVING KIDNEY DONATION AND KIDNEY TRANSPLANTATION
by: Ekamol Tantisattamo, et al.
Published: (2016-11-01)

Association between metabolic parameters and risks of anemia and electrolyte disturbances among stages 3–5 chronic kidney disease patients in Taiwan
by: Adi Lukas Kurniawan, et al.
Published: (2021-11-01)

PO-03 IMPROVEMENT IN POST-TRANSPLANT HYPERTENSION IN LIVING DONOR RENAL TRANSPLANTATION
by: Ekamol Tantisattamo, et al.
Published: (2016-11-01)

Long term metabolic and renal outcomes of kidney donors compared to controls with excellent kidney function
by: Ayelet Grupper, et al.
Published: (2019-01-01)

Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients
by: Theerawut Klangjareonchai, et al.
Published: (2021-03-01)

Anti-Oxidative Therapy in Diabetic Nephropathy
by: Luis F. Hernandez, et al.
Published: (2022-05-01)

Intraoperative Near-Infrared Spectroscopy Monitoring of Renal Allograft Reperfusion in Kidney Transplant Recipients: A Feasibility and Proof-of-Concept Study
by: Hien Lau, et al.
Published: (2021-09-01)

Alterations in the Mineral Bone Metabolism of Living Kidney Donors After Uni-Nephrectomy: Prospective Observational Study
by: Hanbi Lee, et al.
Published: (2021-10-01)

Sclerostin Blood Levels Before and After Kidney Transplantation
by: Marco Bonani, et al.
Published: (2014-07-01)

Outcomes in Living Donor Kidney Transplantation: The Role of Donor’s Kidney Function
by: Massimo Torreggiani, et al.
Published: (2021-02-01)

Older-to-Older Living Kidney Transplantation: A New Paradigm
by: Cátia Raquel Figueiredo, et al.
Published: (2022-06-01)

Long-term safety in living kidney donors for paediatric transplantation. Single-centre prospective study
by: Javier Martin, et al.
Published: (2016-11-01)

Kidney transplantation outcomes: Single center experience
by: Jamilya Saparbay, et al.
Published: (2022-09-01)

Kidney Transplantation in Iran
by: Behzad Einollahi
Published: (2010-03-01)

Mineral and Bone Disorders After Kidney Transplantation
by: Chandan Vangala, et al.
Published: (2018-07-01)

Kidney Transplantation in Kazakhstan: 10-Year Single Center Experience
by: Jamilya Saparbay, et al.
Published: (2021-06-01)

Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
by: F U Dzgoeva, et al.
Published: (2014-06-01)

Coronary Artery Disease Screening of Asymptomatic Kidney Transplant Candidates: A Web-Based Survey of Practice Patterns in the United States
by: Xingxing S. Cheng, et al.
Published: (2020-07-01)

The association of metabolic syndrome components and chronic kidney disease in patients with hypertension
by: Kun Xie, et al.
Published: (2019-12-01)

Correlation between soluble klotho and chronic kidney disease–mineral and bone disorder in chronic kidney disease: a meta-analysis
by: Zhongyu Fan, et al.
Published: (2024-02-01)

Cadaver transplantation in Recent Era: Is Cadaveric Graft Survival Similar to Living Kidney Transplantation?
by: N. Simforoosh, et al.
Published: (2011-10-01)

Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease
by: Fan Li, et al.
Published: (2023-12-01)

Is a Patient with Paget’s Disease of Bone Suitable for Living Kidney Donation?—Decision-Making in Lack of Clinical Evidence
by: Paweł Poznański, et al.
Published: (2022-03-01)

Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study
by: Nadine Heimgartner, et al.
Published: (2020-09-01)

Current status and future aspects of kidney transplantation in Japan
by: Atsushi Aikawa
Published: (2018-11-01)

Recommendations for living donor kidney transplantation
by: Miguel Ángel Frutos, et al.
Published: (2022-12-01)

Bone health in autosomal dominant polycystic kidney disease (ADPKD) patients after kidney transplantation
by: Dalia Zubidat, et al.
Published: (2023-06-01)

Safety, clinical and laboratory characteristics of donors with thalassemia minor in living donor kidney transplant: a case series
by: Nhan Hieu Dinh, et al.
Published: (2021-12-01)

Recipient efficacy and safety of kidney transplantation from older living donor: consideration for using older kidney as a solution to the shortage of organs
by: Ji Yeon Song, et al.
Published: (2021-12-01)

Fibroblast growth factor 23 and lipid metabolism association in chronic kidney disease
by: M. I. Chaikovska, et al.
Published: (2018-05-01)

Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
by: F U Dzgoeva, et al.
Published: (2015-06-01)

Nrf2 Pathway and Oxidative Stress as a Common Target for Treatment of Diabetes and Its Comorbidities
by: Michelle Yi, et al.
Published: (2024-01-01)

Nutrition Disturbances and Metabolic Complications in Kidney Transplant Recipients: Etiology, Methods of Assessment and Prevention—A Review
by: Monika Górska, et al.
Published: (2022-11-01)

Risk Factors for Developing Low Estimated Glomerular Filtration Rate and Albuminuria in Living Kidney Donors
by: Anisha Dhalla, et al.
Published: (2024-02-01)